ArticleLeukemia2025

Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?

Nicolas Gazeau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.